Oxyband Technologies Names Jim Walsh Chief Operating Officer

ST. LOUIS - July 25, 2013 - PRLog -- St. Louis, Missouri … Oxyband Technologies, Inc., a medical technology company dedicated to delivering medical devices and information technologies enabling healthcare industries to provide better, safer care, announced today that Jim Walsh has joined the executive team as Chief Operating Officer (COO). Mr. Walsh was previously Senior Vice President, Federal Government Sector, for McKesson Corporation.  In his new role, Walsh will manage Oxyband’s overall operations and expansion of Oxyband products across all healthcare segments.

OxyBand Technologies™ (http://oxyband.com) is the first company to package pure oxygen into a discrete wound dressing using its directionally permeable gas-emitting reservoir.  The company was founded by scientists and engineers to develop evidence-based medical technology devices to improve outcomes for wounded soldiers and patients around the world.  Oxyband Technologies™ has production offices in St. Louis at 10440 Trenton Avenue.  

For more than ten years, Mr. Walsh oversaw McKesson’s federal and state engagements and developed corporate strategies for expansion within the sector, resulting in revenues exceeding $5 billion. Before joining McKesson, he held executive positions with Exostar and Concurrent Technologies Corporation and previously served in the U.S. Army.

Mr. Walsh retired from the Army in 1996 after 26 years of honorable service. Among his many assignments were:  Office of the Assistant Secretary of the Army (RD&A), Director of Contracting, Walter Reed Army Medical Center; Director of Logistics, SHAPE Medical Center; and a joint medical assignment with the Defense Logistics Agency.  As a Medical Service Corps officer, Mr. Walsh’s career progressed from field medicine and medical evacuation pilot to medical logistics/contracting, and he also managed the Department of the Army’s worldwide electronic commerce network. From 1967 through 1975, he served as a noncommissioned officer with the Army Security Agency and the 11^th Special Forces Group (ABN). His combat duty includes two tours in South Vietnam and Bosnia.

Mr. Walsh’s military awards and professional recognition include the Legion of Merit, Bronze Star, Federal 100 (1997) and Senior Army Aviator Wings. He earned a B.A. degree from Rutgers University, a MBA from Boston University and MIS from Drexel University.

About Oxyband Technologies™

OxyBand Technologies™ (http://oxyband.com) is the first company to package pure oxygen into a discrete wound dressing using its directionally permeable gas-emitting reservoir.  The company was founded by scientists and engineers to develop evidence-based medical technology devices to improve outcomes for wounded soldiers and patients around the world.  The OxyBand Wound Dressing is the only FDA-approved wound dressing proven to continuously deliver pure oxygen to damaged tissue for up to 96 hours. The manufacturing of this innovative wound care dressing occurs at Lighthouse for the Blind-St. Louis, (LHB), a nonprofit organization that offers employment, education and support services to children and adults who are visually impaired.  OxyBand™ wound dressings are FDA-approved for use on acute wounds, first and second degree burns, abrasions, skin tears, blisters, lacerations, closed surgical  incisions, skin graft donor sites, Stage I or II pressure ulcers, pressure sores, chafed  skin and skin continuously exposed to moisture. The waterproof barrier provides protection from outside contaminants while the patented system continuously provides pure oxygen to the damaged tissue for up to five days. The bandages are currently available in a 9 by 7-inch size and will be offered in additional sizes in late 2013.

For more information about OxyBand, see the website, www.oxyband.com or contact OxyBand via email at information@oxyband.com. For information about Lighthouse for the Blind, visit the website www.lhbindustries.com

or call Brittney Smithers at toll-free 800.542.3697. Media relations contact: Jeff Dunlap at 314 409 5203.